The
global Scaffold
Technology Market size is expected to reach USD 2.1 billion by 2028,
according to a new report by Grand View Research, Inc. The market is expected
to expand at a CAGR of 8.4% from 2021 to 2028. The market growth can be
primarily attributed to the growing popularity of bioprinting for mimicking the
tissue microenvironment in printed 3D tissue models. The need to expand the
horizon of multidisciplinary research areas has supplemented the adoption of
scaffold technologies in 3D printed models.
For
instance, in October 2021, researchers integrated novel biomaterial
scaffold-guided regeneration for multiple periodontal tissues. The
incorporation of advanced imaging modalities along with 3D printing has
facilitated non-invasive tracking of in vivo degradation of scaffolds. The
advent of such technologies is expected to propel the adoption of scaffolds in
tissue engineering and regeneration, thereby providing considerable momentum to
market growth.
Additionally,
the development of novel diagnostic and therapeutic strategies such as tissue
engineering, regenerative medicine, have been largely favored in the wake
of the pandemic outbreak of SARS-COV-2 infection. Expanding research activities
in the field of tissue engineering have led to the advent of scaffold-based
vaccine systems, which have the potential tocombatCOVID-19. Progress in this
area is expected to cause a surge in the adoption of advanced medical
technologies in COVID-19 vaccine development and research.
Furthermore,
researchers are proactively using in vitro human lung tissue models developed
using tissue-engineered for the understanding of mechanisms of the infection
and host-pathogen interface. The application of tissue engineering is used for
culturing multiple pulmonary cell lines, improving the relevance of in vitro
models, and the use of 3D scaffolds that mimic native pulmonary architecture.
Related Press
Release@ Scaffold
Technology Market Report
Scaffold Technology Market Report Highlights
- The
hydrogels segment dominated the market in terms of revenue in 2020 owing
to advantages such as high biocompatibility, thermal reversibility, and
strong cellular activities, contributing to its increasing adoption rate
- The
nanofiber-based scaffolds segment is expected to witness lucrative growth
owing to the growing advancements such as 3D molding for developing 3D
nanofiber membranes
- The stem
cell therapy, regenerative medicine, and tissue engineering segment held
the largest revenue share in 2020
- This growth
is attributed to the expanding adoption of scaffolds in the aesthetic
procedure, wound healing, periodontology, and colorectal surgeries
- The drug
discovery segment is expected to witness the fastest CAGR over the
forecast period
- Scaffolds
play a vital role in the elucidation of molecular reasons for the activity
of drug candidate in toxicity screening procedures, which is expected to
impact the growth of medical technology in this segment
- The
orthopedics, musculoskeletal, and spine segment held a substantial market
share in 2020 due to an increase in the popularity of regenerative
medicines
- Regenerative
medicines can offer various lower risk substitutes to allograft surgery,
thereby supplementing the adoption of the technology in this segment
- The
biotechnology and pharmaceutical industries segment dominated the market
in terms of revenue share in 2020 owing to their high engagement in new
drug discovery and development
- North
America held the largest revenue share in 2020. Growth in this region is
owing to the presence of key players and extensive R&D activities
- Companies
operating in the market are entering into partnership for developing 3D
cell culture models
- For
instance, in March 2021, PELOBiotech GmbH entered in partnership with
Rigenerand SRL for developing 3D Cell Culture models. The company
distributed its VITVO handheld bioreactor which is integrated with a
scaffold for establishing in vitro 3D cell culture model that is used in
pre-clinical investigations and research applications
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment